Global In-Vitro Diagnostics Market Report 2023-2028: Rising Demand for Automated IVD Systems in Hospitals & Laboratories - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "In-Vitro Diagnostics Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's offering.

The global in-vitro diagnostics market is expected to witness a promising future, with opportunities in the hospitals, laboratories, and home care end-use industries.

The market is projected to reach an estimated value of $127.3 billion by 2028, growing at a CAGR of 5% from 2023 to 2028. The major drivers of this growth are the increasing prevalence of chronic diseases and the rising demand for automated IVD systems in hospitals and laboratories to ensure accurate, error-free, and efficient diagnoses.

Infectious diseases are expected to remain the largest segment due to the prevalence of life-threatening diseases like HIV/AIDS, tuberculosis, hepatitis, and pneumonia. Laboratories are projected to dominate due to growing awareness about personalized medicine and advanced equipment availability. North America is anticipated to lead the market with a well-established healthcare infrastructure, a rising geriatric population, and increased healthcare expenditure.

Major players in the in-vitro diagnostics market compete based on product quality and invest in R&D, manufacturing facilities, and infrastructural development to meet the increasing demand and enhance competitive effectiveness. Companies profiled in the report include Abbott, bioMerieux, Bio-Rad, Siemens Healthineers, and Qiagen.

The report provides valuable insights into the in-vitro diagnostics market, including trend analysis, segmentation by various factors, regional breakdown, growth opportunities, and strategic analysis based on Porter's Five Forces model.

Key Topics Covered

1. Executive Summary

2. Global In-Vitro Diagnostics Market: Market Dynamics

2.1: Introduction, Background, and Classifications

2.2: Supply Chain

2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)

3.2: Global In-Vitro Diagnostics Market Trends (2017-2022) and Forecast (2023-2028)

3.3: Global In-Vitro Diagnostics Market by Application

3.3.1: Instruments

3.3.2: Reagents

3.3.3: Services

3.4: Global In-Vitro Diagnostics Market by Application

3.4.1: Infectious Diseases

3.4.2: Diabetes

3.4.3: Oncology

3.4.4: Cardiology

3.4.5: Nephrology

3.4.6: Autoimmune Diseases

3.4.7: Drug Testing

3.4.8: Others

3.5: Global In-Vitro Diagnostics Market by Technology

3.5.1: Immunoassay

3.5.1.1: Instruments

3.5.1.2: Reagents

3.5.1.3: Services

3.5.2: Hematology

3.5.2.1: Instruments

3.5.2.2: Reagents

3.5.2.3: Services

3.5.3: Clinical Chemistry

3.5.3.1: Instruments

3.5.3.2: Reagents

3.5.3.3: Services

3.5.4: Molecular Diagnostics

3.5.4.1: Instruments

3.5.4.2: Reagents

3.5.4.3: Services

3.5.5: Coagulation

3.5.5.1: Instruments

3.5.5.2: Reagents

3.5.5.3: Services

3.5.6: Microbiology

3.5.6.1: Instruments

3.5.6.2: Reagents

3.5.6.3: Services

3.5.7: Others

3.5.7.1: Instruments

3.5.7..2: Reagents

3.5.7.3: Services

3.6: Global In-Vitro Diagnostics Market by End Use Industry

3.6.1: Hospitals

3.6.2: Laboratories

3.6.3: Home Care

3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

4.1: Global In-Vitro Diagnostics Market by Region

4.2: North American In-Vitro Diagnostics Market

4.3: European In-Vitro Diagnostics Market

4.4: APAC In-Vitro Diagnostics Market

4.5: RoW In-Vitro Diagnostics Market

5. Competitor Analysis

5.1: Product Portfolio Analysis

5.2: Operational Integration

5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis

6.2: Emerging Trends in the Global In-Vitro Diagnostics Market

6.3: Strategic Analysis

6.3.1: New Product Development

6.3.2: Capacity Expansion of the Global In-Vitro Diagnostics Market

6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In-Vitro Diagnostics Market

6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

7.1: Abbott

7.2: bioMerieux

7.3: Bio-Rad

7.4: Siemens Healthineers

7.5: Qiagen

For more information about this report visit https://www.researchandmarkets.com/r/c0vbfo

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.